Does modern medicine increase life-expectancy: Quest for the Moon Rabbit?

Thrombolysis The Fibrinolytic Therapy Trialists’ Collaborative Group evaluated 9 trials including 58,600 patients and demonstrated highly significant absolute mortality reductions of about 30 per 1000 for those presenting within 0–6 h and of about 20 per 1000 for those presenting 7–12 h from onset but a (statistically) uncertain benefit of about 10 per 1000 for those presenting at 13–18 h.

also in 132,142 other papers